Related Experiment Video
Updated: Nov 18, 2025

08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.1K
Malignant Pleural Mesothelioma: Time Is Running Out
1Università Cattolica del Sacro Cuore, 20123 Rome, Italy.
Journal of Clinical Medicine
|February 11, 2021
Summary
Malignant pleural mesothelioma (MPM) is a rare cancer linked to asbestos. Research focuses on understanding its aggressive nature and improving patient outcomes.
Area of Science:
- Oncology
- Pulmonology
- Environmental Medicine
Background:
- Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer originating in the pleura.
- Asbestos exposure is the primary etiological factor for MPM.
- Diagnosis and treatment of MPM remain challenging due to its rarity and aggressive nature.
Discussion:
- MPM's pathogenesis involves complex molecular alterations following asbestos fiber inhalation.
- Current therapeutic strategies for MPM include surgery, chemotherapy, and radiation therapy, often in combination.
- The prognosis for MPM is generally poor, highlighting the need for novel treatment approaches.
Key Insights:
- Understanding the molecular mechanisms driving MPM is crucial for developing targeted therapies.
- Early detection and accurate staging are critical for effective management of MPM.
- Multidisciplinary care approaches offer the best outcomes for patients with MPM.
Outlook:
- Future research directions include exploring novel immunotherapies and targeted agents for MPM treatment.
- Improving diagnostic tools and biomarkers for earlier MPM detection is an ongoing effort.
- Investigating the long-term health effects of asbestos exposure and developing preventative measures remain important.
More Related Videos
Related Concept Videos
Pleural Disorders: Types and Brief Description
422
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
422
Pleural Effusion II: Symptoms and Management
410
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
410
Pleura of the Lungs
4.7K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
4.7K
Pleural Effusion I: Introduction
2.9K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.9K
Pneumothorax-II
599
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
599
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K

